【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2013 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2013 14
2.2.1 AstraZeneca to Acquire Remaining 50% Interest in Diabetes Joint Venture from Bristol-Myers Squibb for US$4.3 Billion 14
2.2.2 Johnson & Johnson Prices Public Offering of Notes for US$3.5 Billion 15
2.2.3 OncoMed Pharma Enters into Co-Development Agreement with Celgene 16
2.2.4 Thermo Fisher Scientific Completes Public Offering of Notes for US$3.2 Billion 17
2.2.5 Genmab Expands Licensing Agreement With Janssen Biotech 18
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2013 19
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2013 20
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2013 21
3.1.1 Top M&A Deals in December 2013 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2013 – December 2013 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2013 24
3.2.1 Top Equity Offering Deals in December 2013 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2013 – December 2013 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2013 27
3.3.1 Top PE/VC Deals in December 2013 28
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2013 29
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2013 30
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2013–December 2013 32
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2013–December 2013 33
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2013 34
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2013 – December 2013 36
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2013 37
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2013 38
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 39
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2013 – December 2013 41
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2013 – December 2013 42
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2013 – December 2013 44
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2013 46
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2013 48
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2013 49
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2013 50
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2013 50
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2013 – December 2013 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 53
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2013 – December 2013 55
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2013 – December 2013 57
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 59
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2013 59
6.1.1 Oncology – Deals of the Month 61
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2013 63
6.2.1 Central Nervous System – Deals of the Month 65
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2013 67
6.3.1 Infectious Diseases – Deals of the Month 69
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2013 70
6.4.1 Metabolic Disorders – Deal of the Month 72
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2013 73
6.5.1 Immunology – Dealsof the Month 75
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2013 76
6.6.1 Cardiovascular – Deal of the Month 77
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, December 2013 78
6.7.1 Respiratory – Deals of the Month 79
7 Deal Summary by Geography 80
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2013 80
7.1.1 North America – Deals of the Month 81
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2013 83
7.2.1 Europe – Deals of the Month 85
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2013 86
7.3.1 Asia-Pacific – Deals of the Month 88
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2013 89
7.4.1 Rest of the World – Deals of the Month 90
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 91
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2013 – December 2013 91
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2013 – December 2013 93
9 Further Information 95
9.1 Methodology 95
9.2 About GlobalData 96
9.3 Disclosure information 97
9.4 Disclaimer 97
【レポート販売概要】
■ タイトル:事業提携・ライセンシング・投資・M&A動向:December 2013(製薬業界)■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for December 2013 in Pharmaceuticals
■ 発行日:2014年1月27日
■ 調査会社:GlobalData
■ 商品コード:GDATA403163519
■ 調査対象地域:グローバル
- 自動車ステアリングの世界市場予測(~2021年):手動、HPS、EHPS、EPS、油圧ポンプ、ステアリングセンサ、ステアリングコラム、モータThe global steering market is projected to grow at a CAGR of 6.47% from 2016 to 2021, to reach a market size of USD 42.77 Billion by 2021. Stringent emission norms, the growing demand for driving comfort from consumers, and increasing vehicle production have fueled the growth of the steering market. The Asia-Oceania steering market is projected to grow at the highest CAGR during the forecast perio …
- 消化薬の世界市場2018-2022About Digestive Remedies Digestive remedies are used for the treatment of gastrointestinal (GI) disorders. The most common digestive disorders are indigestion, heartburn, diarrhoea, irritable bowel syndrome (IBS), motion sickness, paediatric digestive disorders, and constipation. Technavio’s analysts forecast the Global Digestive Remedies Market to grow at a CAGR of 4.1% during the period 2018-202 …
- Petrichor Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- 2012Petrichor Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Petrichor Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 新生児発作治療のグローバル臨床試験動向(2014年H2)Neonatal Seizures Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment s …
- 液体・ガス濾過装置/精製装置市場(~2019):世界市場The expansion of the global liquid and gas filtering and purifying equipment industry is forecast to reach 4.0% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.2%. Currently, water filtering and purifying equipment accounts for 12.1% of the global demand while the remaining market share is divided between other beverage filtering and purifyin …
- 救命救急診療の世界市場分析:テスト別(ルーチン・特殊化学、フローサイトメトリー、血液学、免疫タンパク質、微生物および感染症、凝固試験)、エンドユーザー別(手術室、緊急治療室、集中治療室)、地域別(米国、カナダ、ドイツ、英国、中国、インド、ブラジル、メキシコ、南アフリカ)、セグメント予測The global critical care diagnostics market is expected to reach USD 1.29 billion by 2024, according to a new report by Grand View Research, Inc. The critical care diagnostics market is expected to grow at a lucrative rate in the next few years. The key factors supporting the industry’s growth comprise the rapid awareness and acknowledgment of these tests by physicians and patients, the rise in ge …
- 輸送管理システム(TMS)の世界市場2015-2019About TMS TMS is used to plan freight movements. It helps customers plan and execute transportation efficiently across the supply chain. It offers a number of services such as strategic planning and optimization, freight consolidation, and freight audit and payment, which helps maximize efficiency and reduce transportation costs. TMS also helps businesses improve their logistics by reducing transp …
- 医療産業用特殊ガスの世界市場ABSTRACTAbout Specialty Gases Specialty gases are a class of high-purity gases that require precise blending of component gases in a gas mixture. Specialized preparation methods and laboratory analysis are used to quantify the component gases in the mixture of gases. This is to obtain high-quality gases with minimal impurities. Advanced production processes, instrumentation, and analytical measure …
- 世界のレーダー (Radar)市場動向(2014-2018)TechNavio's analysts forecast the Global Radar market to grow at a CAGR of 12.43 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand from developing nations. The Global Radar market has also been witnessing the increased usage of solid state electronics. However, the increasing regulatory barriers could pose a challenge to the growt …
- Equal Energy Ltd:石油・ガスバリューチェーン分析レポート2013Equal Energy Ltd Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Equal Energy Ltd" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Equal Energy Ltd”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the com …
- 人工心臓弁(医療機器)のグローバル新興国市場(2012-2018)The Cardiac Prosthetic Heart Valves market value is expected to reach US$468 million by 2016, primarily supported by the product types - Mechanical Heart Valves, Transluminal Heart Valves and Tissue Heart Valves. China accounts for nearly 26% of the market share and India claims more than 20% of the total share. In terms of CAGR, India is the fastest growing region while China and South Korea are …
- ナトリウム・リグノスルホン酸塩の世界市場Sodium Lignosulfonate (CAS 8061-51-6) Market Research Report 2014 presents comprehensive data on sodium lignosulfonate markets globally and regionally (Europe, Asia, North America etc.) The report includes sodium lignosulfonate description, covers its application areas and related patterns. It overviews sodium lignosulfonate market, names sodium lignosulfonate producers and indicates its suppliers …
- 化学療法に伴う貧血:世界の臨床試験レビュー(2014年上半期)Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014" provides data on the Chemotherapy Induced Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Anemia. It includes an overview of t …
- 微小中空ガラス球状体の世界市場Hollow glass microspheres have evolved as a lightweight filler to be used in several industries such as aerospace, automotive, oil & gas, healthcare, and others. They are suitable to be used in various applications such as thermoplastics, rubber & elastomers, abrasive materials, sheet molding compounds, cryogenic technology, thermosets-epoxy, acoustic and thermal insulating materials, polyurethane …
- 軟部組織修復用医療デバイスの世界市場:組織パッチ、同種移植片、異種移植片、縫合糸アンカー、干渉ネジ、胸腔鏡Soft tissue repair products are used to repair and reconstruct soft tissue injuries. The soft tissue repair market is mainly driven by technological advancements, innovative product offerings, increasing incidence of soft tissue injuries among the aging population, increasing participation in sports, and the increasing obesity rate. However, the ambiguity in reimbursement for these products and th …